Close Menu

software

Artificial will provide access to its aLab Suite software, which integrates with the Thermo Scientific Momentum Workflow software and robotics hardware.

BioIQ will offer Fulgent's next-generation sequencing-based coronavirus assay on its diagnostic testing platform.

The companies have agreed to combine their respective liquid handling platforms and analysis software for integrated sample-to-answer PCR workflows.

The deal builds on a non-exclusive partnership signed in January 2019 and PierianDx will now support three more Illumina cancer sequencing assays.

Genosity will combine its Integrated Genomic Toolkit with Israel-based Igentify's genetic counseling software, which both firms will comarket.

The software generates reports for pharmacogenomics, rare diseases, predispositions to common diseases, and nutrigenomics.

The firms are developing clinical and RUO workflows that use NGS for pathogen identification and will comarket IDbyDNA's Explify data platform.

The companies will develop an integrated clinical pathology solution with plans to submit a 510(k) application to the US Food and Drug Administration.

The acquisition, slated to close in the coming days, will give Invitae access to Clear Genetics' chatbot Gia, or Genetic Information Assistant.

By measuring and analyzing hospital testing operations, the firm anticipates helping its customers implement better antimicrobial stewardship programs.

Pages